Financials Credit Analyst

Hank Calenti, CFA

CreditContinuum

Credit

Given its low capital buffer and plans to lower it further, along with high market risk tolerance and leverage finance exposure, <a href="https://www.smartkarma.com/entities/credit-suisse-group-ag" target="_blank" data-smartkarma-citation="entities:22253:1" rel="noopener">Credit Suisse's (CSGN VX)</a> Additional Tier 1 (AT1) trades too tight relative to <a href="https://www.smartkarma.com/entities/ubs-group-ag" target="_blank" data-smartkarma-citation="entities:22590:1" rel="noopener">UBS (UBSG VX)</a> and most other large banks globally. We see better value elsewhere at this point in the credit cycle.Many analysts compare CS and UBS and conclude that they are largely the same, with UBS having deleveraged its investment banking franchise years earlier. We disagree. While both may suffer outflows in assets under management during a prolonged equity market correction, UBS has a far less market-sensitive franchise during intermittent bouts of volatility, as was clearly shown over the past year. In addition to having a higher trading risk tolerance profile, CS appears to have a higher sensitivity to non-investment grade leverage finance and oil &amp; gas exposures.  These are more sensitive to the business cycle. As of now, with global growth set to accelerate post-vaccination, this is a benefit. However, this is also already priced into CS’ securities.  In fact, the longer-dated AT1 bonds are priced to perfection, in our view.In addition, CS has a substantially lower Common Equity Tier 1 (CET1) buffer than UBS and many other European banks.  Furthermore, as CS targets an even lower capital ratio, this buffer is at risk of falling further over the near term. While lofty aspirations to operate at a higher leverage level may be aimed at equity holders, we think it best to take management’s word at face value. Lower capital ratios are not AT1 capital supportive. Unless the firm simultaneously de-risks, sensitivity to non-IG leverage finance and non-IG oil &amp; gas exposures may increase.Furthermore, while we were impressed by Mr. Hoarta-Osório’s leadership at <a href="https://www.smartkarma.com/entities/lloyds-banking-group-plc" target="_blank" data-smartkarma-citation="entities:21009:1" rel="noopener">Lloyds Bank (LLOY LN)</a> in the UK, despite several blemishes, we are surprised that the ex-CEO of a UK-centric mortgage bank would be chosen as Chairman of the Board at a global investment bank with wealth management growth aspirations in Asia. We are not convinced this is the best choice and we question if the execution risk from an eventual strategy pivot will be credit positive.We explore these themes and provide an overview of CS’s Q4 results within. We conclude that, taken together amongst its longer-dated peer-issued AT1 notes, we find better value in <a href="https://www.smartkarma.com/entities/societe-generale-sa" target="_blank" data-smartkarma-citation="entities:21478:1" rel="noopener">Société Générale's (GLE FP)</a> 2030 first call AT1 than in the recently issued Credit Suisse security. (Please see: <a href="https://www.smartkarma.com/insights/societe-generale-s-at1-better-fundamental-and-relative-value-than-bnp" target="_blank" data-smartkarma-citation="insights:48177" rel="noopener">Société Générale’s AT1: Better Fundamental and Relative Value than BNP</a> for more details on SocGen). We also see greater spread pick-up in Credit Suisse’s 2025 first call AT1 note than further out the curve.

Given its low capital buffer and plans to lower it further, along with high market risk tolerance and leverage finance exposure, Credit Suisse's (CSGN VX) Additional Tier 1 (AT1) trades too tight relative to UBS (UBSG VX) and most other large banks globally. We see better value elsewhere at this point in the credit cycle.Many analysts compare CS and UBS and conclude that they are largely the same, with UBS having deleveraged its investment banking franchise years earlier. We disagree. While both may suffer outflows in assets under management during a prolonged equity market correction, UBS has a far less market-sensitive franchise during intermittent bouts of volatility, as was clearly shown over the past year. In addition to having a higher trading risk tolerance profile, CS appears to have a higher sensitivity to non-investment grade leverage finance and oil &amp; gas exposures.  These are more sensitive to the business cycle. As of now, with global growth set to accelerate post-vaccination, this is a benefit. However, this is also already priced into CS’ securities.  In fact, the longer-dated AT1 bonds are priced to perfection, in our view.In addition, CS has a substantially lower Common Equity Tier 1 (CET1) buffer than UBS and many other European banks.  Furthermore, as CS targets an even lower capital ratio, this buffer is at risk of falling further over the near term. While lofty aspirations to operate at a higher leverage level may be aimed at equity holders, we think it best to take management’s word at face value. Lower capital ratios are not AT1 capital supportive. Unless the firm simultaneously de-risks, sensitivity to non-IG leverage finance and non-IG oil &amp; gas exposures may increase.Furthermore, while we were impressed by Mr. Hoarta-Osório’s leadership at Lloyds Bank (LLOY LN) in the UK, despite several blemishes, we are surprised that the ex-CEO of a UK-centric mortgage bank would be chosen as Chairman of the Board at a global investment bank with wealth management growth aspirations in Asia. We are not convinced this is the best choice and we question if the execution risk from an eventual strategy pivot will be credit positive.We explore these themes and provide an overview of CS’s Q4 results within. We conclude that, taken together amongst its longer-dated peer-issued AT1 notes, we find better value in Société Générale's (GLE FP) 2030 first call AT1 than in the recently issued Credit Suisse security. (Please see: Société Générale’s AT1: Better Fundamental and Relative Value than BNP for more details on SocGen). We also see greater spread pick-up in Credit Suisse’s 2025 first call AT1 note than further out the curve.

Credit Suisse – Perfection Priced into Long-Dated AT1

Silver Point

Thomas J. Monaco

Independent Insight Provider

Silver Point is a boutique research firm that focuses on the broader financial services sector, with a particular focus on troubled institutions globally. 

Asia Ex Japan

Equity Bottom-Up

*Super Results And Will Only Get Better: JP Morgan Chase &amp; Co (JPM.US) [JPM] reported 4Q20 bottom-line results of USD 12.1 bn, increasing USD 2.7 bn (28.5%) linked quarter. On a core operating basis, we note an even stronger QOQ improvement, with numbers coming in at USD 12.1 bn or USD 3.1 bn (34.6%) higher than 3Q20. Results were essentially driven by a reserve reversal of USD 1.9 bn, which no doubt will be a consistent theme in 2021;*Credit Weakness Significantly Decelerates: We find that net new NPLs on a linked quarter amounted to only USD 1 mn or well under 1.0% on an annualized basis. The pace of increase has decelerated from the 7.0% and 26% posted in 3Q20 and 2Q20, respectively; and*Solid Share Buyback In Place: JPM noted that it could repurchase a maximum number of shares of USD 4.5 bn for 1Q21.

*Super Results And Will Only Get Better: JP Morgan Chase &amp; Co (JPM.US) [JPM] reported 4Q20 bottom-line results of USD 12.1 bn, increasing USD 2.7 bn (28.5%) linked quarter. On a core operating basis, we note an even stronger QOQ improvement, with numbers coming in at USD 12.1 bn or USD 3.1 bn (34.6%) higher than 3Q20. Results were essentially driven by a reserve reversal of USD 1.9 bn, which no doubt will be a consistent theme in 2021;*Credit Weakness Significantly Decelerates: We find that net new NPLs on a linked quarter amounted to only USD 1 mn or well under 1.0% on an annualized basis. The pace of increase has decelerated from the 7.0% and 26% posted in 3Q20 and 2Q20, respectively; and*Solid Share Buyback In Place: JPM noted that it could repurchase a maximum number of shares of USD 4.5 bn for 1Q21. 

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

MSCI Emerging Markets Index / Technical Analysis

As we highlighted in last week’s Int’l Compass, the weight of the evidence suggests commodities are in the early stages of a new secular bull market. Global Materials remains a favorite Sector overweight and we believe outperformance is likely to continue considering the Sector’s long-term bullish RS reversal. Additionally, we are upgrading equal-weighted Energy to overweight due to bullish price and RS inflections -- add exposure with a focus on small- and mid-caps.

As we highlighted in last week’s Int’l Compass, the weight of the evidence suggests commodities are in the early stages of a new secular bull market. Global Materials remains a favorite Sector overweight and we believe outperformance is likely to continue considering the Sector’s long-term bullish RS reversal. Additionally, we are upgrading equal-weighted Energy to overweight due to bullish price and RS inflections -- add exposure with a focus on small- and mid-caps.

Global Commodity-Related Equity Sectors In Secular Bull

Positive COVID vaccine news has since led to bullish inflections in a staggering number of countries, ACWI-US included. Our current outlook is bullish. Buy dips. In this report we outline key technical levels across markets and highlight actionable ideas within our Financials &amp; Energy Sectors.

Positive COVID vaccine news has since led to bullish inflections in a staggering number of countries, ACWI-US included. Our current outlook is bullish. Buy dips. In this report we outline key technical levels across markets and highlight actionable ideas within our Financials &amp; Energy Sectors.

*First Out Of The Gate: J.P, Morgan &amp; Co. (JPM.US) [JPM] reported 3Q20 results of USD 9.3 bn or USD 2.92 per share – well ahead of consensus of USD 2.22 per share. Results improvement was led primarily by JPM’s USD 9.9 bn (94.2%) reduction in loss provisions on a linked quarter basis. Offsetting the stellar bottom-line performance, we note several troubling trends: a) net interest income declined on the back of NIM compression and loan portfolio contraction; b) a significant decline in capital markets related revenues; and c) expenses increases;    *Credit Weakness Decelerates: Despite calculating that NCOs were actually a negative USD 1.4 bn, we find that net new NPLs linked quarter amounted to a positive USD 184 mn or 7.0% on an annualized basis. While still weakening, the pace of increase has decelerated from the 26% posted in 2Q20; and* CAPM and Cost Pressure: Volatile capital markets-related revenues took a bit of a digger – declining USD 3.9 bn (26.7%) linked quarter - representing a declining 66.9% of total revenues at 3Q20 (down from the 77.0% posted at 2Q20). When we exclude compensation costs which have a large variable component, we note that the more fixed expenses increased. Comp/revenue, despite the overall bottom-line improvement, worsened to 53.5% - up 3.8% during the period while JPM’s efficiency ratio worsened to 57.9% versus 51.4% in 2Q20.

*First Out Of The Gate: J.P, Morgan &amp; Co. (JPM.US) [JPM] reported 3Q20 results of USD 9.3 bn or USD 2.92 per share – well ahead of consensus of USD 2.22 per share. Results improvement was led primarily by JPM’s USD 9.9 bn (94.2%) reduction in loss provisions on a linked quarter basis. Offsetting the stellar bottom-line performance, we note several troubling trends: a) net interest income declined on the back of NIM compression and loan portfolio contraction; b) a significant decline in capital markets related revenues; and c) expenses increases;    *Credit Weakness Decelerates: Despite calculating that NCOs were actually a negative USD 1.4 bn, we find that net new NPLs linked quarter amounted to a positive USD 184 mn or 7.0% on an annualized basis. While still weakening, the pace of increase has decelerated from the 26% posted in 2Q20; and* CAPM and Cost Pressure: Volatile capital markets-related revenues took a bit of a digger – declining USD 3.9 bn (26.7%) linked quarter - representing a declining 66.9% of total revenues at 3Q20 (down from the 77.0% posted at 2Q20). When we exclude compensation costs which have a large variable component, we note that the more fixed expenses increased. Comp/revenue, despite the overall bottom-line improvement, worsened to 53.5% - up 3.8% during the period while JPM’s efficiency ratio worsened to 57.9% versus 51.4% in 2Q20.

JP Morgan & Co. – Good Credit Omen For US and Global Banks

Switzerland

Credit Suisse Group AG operates as a wealth management firm. The Company specializes in investment banking and offers wealth management activities aiming to capitalize on both the large pool of wealth within mature markets, as well as the significant growth in wealth in Asia Pacific and other emerging markets. Credit Suisse Group serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Credit Suisse Group (CSGN SW)

Credit Suisse – Perfection Priced into Long-Dated AT1

Many analysts compare CS and UBS and conclude that they are largely the same. We disagree. Given its low capital buffer, higher leverage finance...

Hank Calenti, CFA

JP Morgan Chase & Co. – Just Wow

JP MORGAN CHASE: JPM] reported 4Q20 bottom-line results increased 28.5% linked quarter, driven by a reserve reversal. Net new NPLs on a linked...

Thomas J. Monaco

Bullish Inflections Around The World

In this report we outline key technical levels across markets and highlight actionable ideas within our Financials & Energy Sectors.

Vermilion Research

JP Morgan & Co. – Good Credit Omen For US and Global Banks

JPM Results, A Good Credit Omen For US and Global Banks. Reserve Reversals Likely To Be A Trend For 4Q20 Results Season -Although Issues Persist

Thomas J. Monaco

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Credit Suisse – Perfection Priced into Long-Dated AT1

Many analysts compare CS and UBS and conclude that they are largely the same. We disagree. Given its low capital buffer, higher leverage finance...

Hank Calenti, CFA

JP Morgan Chase & Co. – Just Wow

JP MORGAN CHASE: JPM] reported 4Q20 bottom-line results increased 28.5% linked quarter, driven by a reserve reversal. Net new NPLs on a linked...

Thomas J. Monaco

Global Commodity-Related Equity Sectors In Secular Bull

We believe commodities are in the early stages of a new secular bull market. Global Materials & Energy remain our favorite Sector overweights - add...

Vermilion Research

Bullish Inflections Around The World

In this report we outline key technical levels across markets and highlight actionable ideas within our Financials & Energy Sectors.

Vermilion Research

JP Morgan & Co. – Good Credit Omen For US and Global Banks

JPM Results, A Good Credit Omen For US and Global Banks. Reserve Reversals Likely To Be A Trend For 4Q20 Results Season -Although Issues Persist

Thomas J. Monaco